What is Beacon Biomedical?
Beacon Biomedical is dedicated to developing highly accurate, affordable, and easy-to-administer point-of-care tests for the early detection of cancers. The company's innovative approach focuses on identifying, securing, and leveraging existing technologies synergistically, rather than inventing new biomarkers or devices. This strategy allows Beacon Biomedical to accelerate the market entry of promising screening technologies, keeping costs down and ensuring affordability for widespread adoption. Their business model prioritizes rapid evaluation and deployment of proven technologies to create effective point-of-care cancer screening solutions.
How much funding has Beacon Biomedical raised?
Beacon Biomedical has raised a total of $750K across 1 funding round:
Angel/Seed
$750K
Angel/Seed (2016): $750K, investors not publicly disclosed
What's next for Beacon Biomedical?
With its recent major strategic investment, Beacon Biomedical is poised to further scale its operations and enhance its product development pipeline. The enterprise-level funding suggests a focus on expanding market reach and potentially developing new diagnostic capabilities. This capital infusion will likely support advancements in their point-of-care testing technology, aiming to solidify their position as a leader in accessible cancer screening solutions and ultimately contribute to saving lives through earlier detection.
See full Beacon Biomedical company page
